Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.

NCT04239469 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia
Cannabis

Interventions

DRUG: KL16-012
DRUG: Placebo

Sponsor

Knop Laboratorios